End-point definition and trial design to advance tuberculosis vaccine development (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1183/16000617.0044-2022

Publication URI: http://dx.doi.org/10.1183/16000617.0044-2022

Type: Journal Article/Review

Parent Publication: European Respiratory Review

Issue: 164

ISSN: 0905-9180